Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination.
Velentgas P, Amato AA, Bohn RL, Chan KA, Cochrane T, Funch DP, Dashevsky I, Duddy AL, Gladowski P, Greenberg SA, Kramer JM, McMahill-Walraven C, Nakasato C, Spettell CM, Syat BL, Wahl PM, Walker AM, Zhang F, Brown JS, Platt R.
Velentgas P, et al. Among authors: funch dp.
Pharmacoepidemiol Drug Saf. 2012 Dec;21(12):1350-8. doi: 10.1002/pds.3321. Epub 2012 Jul 16.
Pharmacoepidemiol Drug Saf. 2012.
PMID: 22807266